Intermediate HCC – the evolving role of Immunotherapy with Multimodality approaches

(27:13)

Highlights: Intermediate HCC – treatment options and strategies

(4:53)

Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options \u0026 Strategies

(20:20)

Dr. Timothy Pawlik - Intermediate stage HCC

(26:31)

Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages

(59:48)

Evidence-Based Treatment Selection and Sequencing in Advanced HCC

(1:37:24)

Intermediate HCC – treatment options and strategies

(20:20)

Intermediate HCC – treatment options and strategies

(1:)

Highlights: Intermediate HCC – The evolving role of IO

(5:36)

The evolving role of IO in intermediate HCC

(51)

Improving Outcomes for Intermediate and Advanced HCC: A Multidisciplinary Tumor Board

(1:18:27)

Intermediate HCC – The evolving role of IO

(27:13)

2nd line treatment in advanced HCC and when to switch

(26:19)

It Takes a Team to Improve HCC Outcomes

(1:31:51)

Improving Outcomes in Intermediate to Advanced HCC: A Multidisciplinary Tumor Board

(40:13)

Intermediate-stage HCC: Exploring Treatment Options

(4:34)

An Expert's Insights on Combination TACE Plus Sorafenib for Intermediate HCC

(37)

Professor Masatoshi Kudo：Novel Treatment Strategy in Intermediate-Stage HCC

(12:19)

Highlights - The evolving role of IO in intermediate HCC

(5:36)

Transarterial Chemoembolization for Intermediate-stage Hepatocellular Carcinoma (Vascular)

(2:30)